Our Team.

Reinhard has been working in the pharmaceutical, biotech, and generics industries for more than 25 years and has a strong track record in management, startups, product development, and commercialization. He has led the development of therapies from early research through clinical development and regulatory approval in the United States, Europe, and other international markets. He and his teams worked with external experts, regulatory agencies, and advocacy groups to bring science-based treatments to patients. Recently, Reinhard has focused on the development and commercialization of therapies for cancer. He has held positions with Genentech, Boehringer Mannheim, Questcor, Piramal Critical Care, Temple University, and other leading organizations. Reinhard earned both his MD and a doctorate in Medicine from Philipps University in Germany.